Effects of Flossing Versus Tensioner's Mobilization in CBPS

November 17, 2026 updated by: Riphah International University

Effects of Flossing Technique Versus Tensioner's Mobilization in Patient With Cerbvicobrachial Pain Syndrome.

Cervicobrachial pain syndrome (CBPS) which involves pain that begins in the cervical spine and radiates into the shoulder, arm, and occasionally the hand. Neural mobilization is a manual therapy technique used to restore normal mechanical and physiological function of neural tissues. It enhances nerve mobility and circulation while reducing mechanosensitivity and improving the interaction between neural structures and surrounding tissues. Two commonly used neurodynamic techniques include the flossing and the tensioner technique. The flossing technique (slider) focuses on gentle, progressive movements to facilitate nerve gliding, while the tensioner technique applies greater mechanical stress by elongating the nerve from both ends .

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

This randomized clinical trial conducted on 60 selected patients of age 18- 40 years, diagnosed with cervicobrachial pain syndrome (CBPS), through Non probability convenient sampling from Ijaz Amin welfare teaching Hospital Sialkot. These participants were randomly allocated to two groups Group A and Group B by using computerized generated list . Group A will be receiving Flossing technique along with cervical lateral glide + conventional treatment, while the Group B will be receiving tensioner's mobilization in conjunction with cervical lateral glide + conventional treatment. Each participant will receive a total of eighteen treatment sessions over a six-week period. The efficacy of the interventions will be assessed at three points: before the treatment initiation (baseline), after 3 weeks of follow up and at the final follow up of 6 weeks (post treatment). Pain intensity will be evaluated using the Numeric Pain Rating Scale (NPRS), while disability levels will be measured using the Neck Disability Index (NDI), Centralization of symptoms will be measured using the wernick's scale. The cervical active range of motions (CAROMs) will be assessed by goniometry. After the data collection the data will be analyzed by using SPSS version 25.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Punjab Province
      • Sialkot, Punjab Province, Pakistan, 51310
        • Ijaz Amin welfare teaching Hospital sialkot
        • Contact:
        • Sub-Investigator:
          • Hafiza Noreen, MS OMPT

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Participants with informed consent
  • Participants with limited cervical ROM
  • Neck pain radiating to upperlimb (unilateral)
  • Participants with positive ULTT
  • Participants with Articular dysfunction at cervical spine

Exclusion Criteria:

  • Participants younger than 18 years of age with Diagnosed central pain syndrome
  • Participants with Red flags for serious spinal condition ( infection, tumour, osteoporosis, spinal fracture etc)
  • Any trauma to cervical spine or brachial plexus injury
  • Any history of fracture/ surgery in cervical or thoracic spine
  • Limited shoulder ROM
  • Participants with neurological disease/ PIVD of cervical spine
  • Participants with cervical Rib / bilateral radiating

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A

Combine flossing technique and standard physiotherapy treatment + cervical lateral glide for 3 sessions( per week) of 6 weeks.

standard pysiotherapy treatment : Before starting the treatment session in both groups they will receive a standardized physiotherapy treatment that include a Heat pack for 10-15 mints then perform active cervical ROM , cervical isometrics exercises and scapular setting exercises (1-2 sets, 10 repetitions). Also provide activity modification and postural education.

Cervical lateral glide:

Apply a gentle lateral glide to the C5- C6 segment away from the symptomatic side using very slow oscillations, up to the point of first resistance without pain. Each session will contain 3 sets of 30 seconds oscillation.

Flossing technique:

flossing technique (nerve flossing) that targeted the median, radial and ulnar nerve separately. Perform this movement for about 10-15 repetition of 1-3 sets.

Experimental: Group B

Combine Tensioner's mobilization and standard physiothera treatment + cervical lateral glide for 3 session(per week) of 6 weeks

standard physiotherapy treatment: Before starting the treatment session in both groups they will receive a standardized physiotherapy treatment that include a Heat pack for 10-15 mints then perform active cervical ROM , cervical isometrics exercises and scapular setting exercises (1-2 sets, 10 repetitions). Also provide activity modification and postural education.

Cervical lateral glide:

Apply a gentle lateral glide to the C5- C6 segment away from the symptomatic side using very slow oscillations, up to the point of first resistance without pain. Each session will contain 3 sets of 30 seconds oscillation.

Tensioner's mobilization:

Tensioner's mobilization that targeted the median, radial and ulnar nerve separately. Perform this movement for about 10-15 repetition of 1-3 sets.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
NPRS for pain score
Time Frame: 6 weeks

The NPRS is a subjective pain rating scale using an 11-point scale from 0 to 10, where 0 means 'no pain' and 10 means 'intolerable pain'. Participants select the whole number that best represents their level of pain. The reliability is >0.95 with ICC values 0.86 0.95 .

6 weeks
Goniometer for Cervical ROM
Time Frame: 6 weeks

A goniometer is a device that measures an angle or permits the rotation of an object to a definite position. In orthopedics, the former description applies more. It is valid and reliable tool for measuring range of motion .

6 weeks
Neck Disability Index ( NDI ) for functional disability
Time Frame: 6 weeks

NDI is a self-reported questionnaire which is formulated to assess pain that restricts the activities of daily living (ADL); it also helps to determine self-assessed disability. NDI has 10 domains covering pain intensity, personal care, lifting, reading, headaches, concentration, work, driving, sleeping, and recreation. Scores range from 0 to 50, with 50 being the greatest levels of dysfunction. It is a valid and reliable tool with ICC=0.98 .

6 weeks
Wernick's scale for centralization of symptoms
Time Frame: 6 weeks

Wernick's scale is one of the most standardized tool that is used for the measurement of centralization of symptoms. This scale has 0 to 6 scoring grid with six means most distal symptoms that is referred to hand, five means symptoms that is referred to forearm, four means symptoms that is referred to arm, three means symptoms that is referred to shoulder area, two means symptoms that is referred to asymmetrical neck area, one means most proximal symptoms that is referred to central neck pain and zero means there is no pain. Depending upon the anatomical location of pain the patient was inquired to mark their symptoms on wernick's scale. The scale demonstrated excellent validity along with very high inter-rater reliability (κ = 0.96-1.00) .

6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Mehar Un Nisa, Riphah International University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 1, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

November 2, 2026

First Submitted That Met QC Criteria

November 17, 2026

First Posted (Actual)

November 18, 2026

Study Record Updates

Last Update Posted (Actual)

November 18, 2026

Last Update Submitted That Met QC Criteria

November 17, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • Mehar Un Nisa

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.